Reduction of ultraviolet light-induced DNA damage in human colon cancer cells treated with a lactoferrin-derived peptide

Journal of Dairy Science

Volumn 95, Issue 10, 2012, Pages 5552-5560

  Freiburghaus, C ^a   Lindmark Mansson H ^b   Paulsson, M ^a   Oredsson, S ^c  

^a LUND UNIVERSITY   (Sweden)

^b Swedish Dairy Association   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Comet assay; DNA repair; DNA strand break; Lactoferricin4 14

Indexed keywords

ANTINEOPLASTIC AGENT; LACTOFERRICIN 4 14, HUMAN; LACTOFERRICIN 4-14, HUMAN; LACTOFERRICIN B; LACTOFERRIN; PEPTIDE FRAGMENT;

ARTICLE; CELL CYCLE S PHASE; CELL STRAIN CACO 2; COMET ASSAY; DNA DAMAGE; DNA REPAIR; DRUG EFFECT; HUMAN; METHODOLOGY; TUMOR CELL LINE; ULTRAVIOLET RADIATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CACO-2 CELLS; CELL LINE, TUMOR; COMET ASSAY; DNA DAMAGE; DNA REPAIR; HUMANS; LACTOFERRIN; PEPTIDE FRAGMENTS; S PHASE; ULTRAVIOLET RAYS;

EID: 84867101768     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2011-5279     Document Type: Article

References (37)

1. Ahmed F.E. Effect of diet, life style, and other environmental/chemopreventive factors on colorectal cancer development and assessment of the risks. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2004, 22:91-147.
2. Alm K., Berntsson P., Oredsson S.M. Topoisomerase II is nonfunctional in polyamine-depleted cells. J. Cell. Biochem. 1999, 75:46-55.
3. Arnold R.R., Brewer M., Gauthier J.J. Bactericidal activity of human lactoferrin: Sensitivity of a variety of microorganisms. Infect. Immun. 1980, 28:893-898.
4. Asumen M.G., Ifeacho T.V., Cockerham L., Pfandl C., Wall N.R. Dynamic changes to survivin subcellular localization are initiated by DNA damage. Oncol. Targets Ther. 2010, 3:129-137.
5. Bellamy W., Takase M., Yamauchi K., Wakabayashi H., Kawase K., Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1992, 1121:130-136.
6. Berkhout B., van Wamel J.L.B., Beljaars L., Meijer D.K.F., Visser S., Floris R. Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides. Antiviral Res. 2002, 55:341-355.
7. Cho E., Smith-Warner S.A., Spiegelman D., Beeson W.L., van den Brandt P.A., Colditz G.A., Folsom A.R., Fraser G.E., Freudenheim J.L., Giovannucci E., Goldbohm R.A., Graham S., Miller A.B., Pietinen P., Potter J.D., Rohan T.E., Terry P., Toniolo P., Virtanen M.J., Willett W.C., Wolk A., Wu K., Yaun S.-S., Zeleniuch-Jacquotte A., Hunter D.J. Dairy foods, calcium, and colorectal cancer: A pooled analysis of 10 cohort studies. J. Natl. Cancer Inst. 2004, 96:1015-1022.
8. 1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J. Cell. Biochem. 1999, 74:486-498.
9. Duan X.-X., Ou J.-S., Li Y., Su J.-J., Ou C., Yang C., Yue H.-F., Ban K.-C. Dynamic expression of apoptosis-related genes during development of laboratory hepatocellular carcinoma and its relation to apoptosis. World J. Gastroenterol. 2005, 11:4740-4744.
10. Eliassen L.T., Berge G., Leknessund A., Wikman M., Lindin I., Løkke C., Ponthan F., Johnsen J.I., Sveinbjørnsson B., Kogner P., Flægstad T., Rekdal Ø. The antimicrobial peptide, Lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo. Int. J. Cancer 2006, 119:493-500.
11. Ellison R.T., Giehl T.J. Killing of gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Invest. 1991, 88:1080-1091.
12. Elwood P.C., Givens I., Beswick A.D., Fehily A.M., Pickering J.E., Gallacher J. The survival advantage of milk and dairy consumption: An overview of evidence from cohort studies of vascular diseases, diabetes and cancer. J. Am. Coll. Nutr. 2008, 27:723S-734S.
13. Fairbairn D.W., Olive P.L., O'Neill K.L. The comet assay: A comprehensive review. Mutat. Res. 1995, 339:37-59.
14. Fillingham J., Koegh M.-C., Krogan N.J. γ-H2AX and its role in double strand break repair. Biochem. Cell Biol. 2006, 84:568-577.
15. Foster E.R., Downs J.A. Histone H2AX phosphorylation in DNA double strand repair. FEBS J. 2005, 272:3231-3240.
16. Fredlund J.O., Johansson M., Baldetorp B., Oredsson S.M. Abnormal DNA synthesis in polyamine deficient cells revealed by bromodeoxyuridine-flow cytometry technique. Cell Prolif. 1994, 27:243-256.
17. Freiburghaus C., Janicke B., Lindmark-Månsson H., Oredsson S.M., Paulsson M. Lactoferricin treatment decreases the rate of cell proliferation of a human colon cancer cell line. J. Dairy Sci. 2009, 92:2477-2484.
18. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
19. Husseini G.A., O'Neill K.L., Pitt W.G. The comet assay to determine the mode of cell death for the ultrasonic delivery of doxorubicin to human leukemia (HL-60 cells) from Pluronic p105 micelles. Technol. Cancer Res. Treat. 2005, 4:707-711.
20. Jing W., Svendsen J.S., Vogel H.J. Comparison of NMR structures and model-membrane interactions of 15-residue antimicrobial peptides derived from bovine lactoferricin. Biochem. Cell Biol. 2006, 84:312-326.
21. Johansson V.M., Oredsson S.M., Alm K. Polyamine depletion with two different polyamine analogues causes DNA damage in human breast cancer cell lines. DNA Cell Biol. 2008, 27:511-516.
22. Karczewski J.M., Vet J.A.M., Hessels D., Noordhoek J. p53-Independent apoptosis induced by menadione in the human colon carcinoma cell line Caco-2. Ann. N. Y. Acad. Sci. 2000, 915:275-278.
23. León-Sicairos N., Reyes-López M., Ordaz-Pichardo C., de la Garza M. Microbial action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in Entamoeba histolytica. Biochem. Cell Biol. 2006, 84:327-336.
24. Lynch H.T., de la Chapelle A. Hereditary colorectal cancer. N. Engl. J. Med. 2003, 348:919-932.
25. Mader J.S., Richardson A., Salsman J., Top D., de Antueno R., Duncan R., Hoskin D.W. Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria. Exp. Cell Res. 2007, 313:2634-2650.
26. Min S., Krochta J. Inhibition of Penicillium commune by edible whey protein films incorporating lactoferrin, lactoferrin hydrolysate, and lactoperoxidase systems. J. Food Sci. 2005, 70:M87-M94.
27. Olive P.L., Johnston P.J., Banath J.P., Durand R.E. The comet assay: A new method to examine heterogeneity associated with solid tumors. Nat. Med. 1998, 4:103-105.
28. Reinhardt H.C., Yaffe M.B. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr. Opin. Cell Biol. 2009, 21:245-255.
29. Stracker T.H., Usui T., Petrini J.H.J. Taking time to make important decisions: The checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair (Amst.) 2009, 8:1047-1054.
30. Tapia-Alveal C., Calonge T.M., O'Connell M.J. Regulation of Chk1. Cell Div. 2009, 4:8. http://dx.doi.org/10.1186/1747-1028-4-8.
31. Troost F.J., Steijns J., Saris W.H.M., Brummer R.-J.M. Gastric digestion of bovine lactoferrin in vivo in adults. J. Nutr. 2001, 131:2101-2104.
32. van Belzen N. The role of lactoferrin in cancer prevention. Sci. Aliments 2002, 22:461-468.
33. Vogel H.J., Schibli D.J., Jing W., Lohmeier-Vogel E.M., Epand R.F., Epand R.M. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem. Cell Biol. 2002, 80:49-63.
34. Wakabayashi H., Takase M., Tomita M. Lactoferricin derived from milk protein lactoferrin. Curr. Pharm. Des. 2003, 9:1277-1287.
35. Food, nutrition, physical activity and the prevention of cancer: A global perspective 2007, World Cancer Research Fund/American Institute for Cancer Research, AICR, Washington, DC.
36. Yoo Y.-C., Watanabe S., Watanabe R., Hata K., Shimazaki K., Azuma I. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn. J. Cancer Res. 1997, 88:184-190.
37. Zlatanova J., Bishop T.C., Victor J.-M., Jackson V., van Holde K. The nucleosome family: Dynamic and growing. Structure 2009, 17:160-171.